Literature DB >> 19499195

[Septic circulatory shock and septic cardiomyopathy].

K Werdan1, S Hettwer, S Bubel, A Oelke, R S Hoke, R Wimmer, H Ebelt, U Müller-Werdan.   

Abstract

Septic shock is not only a circulatory shock but is also a cardiac shock, the consequence of a potentially reversible heart impairment known as septic cardiomyopathy. Disturbances of macrocirculation as well as microcirculation, an individually heterogeneous reduction of cardiac function, and an extensive impairment of demand-oriented regulation of heart function characterize the septic shock state. Bacterial toxins, inflammatory mediators, and a disseminated intravasal coagulopathy are responsible for these disturbances; for the impairment of cardiac regulation, the interaction of endotoxin with the cardiac pacemaker current I(f) also plays a role. Circulatory shock as well as septic cardiomyopathy should be quantified: The lowering of systemic vascular resistance characterizes the extent of circulatory shock, and the reduction of relative cardiac output in relation to afterload characterizes the extent of septic cardiomyopathy. The intensity of circulatory as well as of cardiac impairment correlates with an unfavorable prognosis. Treatment of septic circulatory shock and of septic cardiomyopathy is predominantly symptomatic; first causal approaches are under investigation.

Entities:  

Mesh:

Year:  2009        PMID: 19499195     DOI: 10.1007/s00108-008-2286-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  26 in total

Review 1.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

2.  Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups.

Authors:  Hendrik Schmidt; Ursula Müller-Werdan; Thomas Hoffmann; Darrel P Francis; Massimo F Piepoli; Mathias Rauchhaus; Roland Prondzinsky; Harald Loppnow; Michael Buerke; Dirk Hoyer; Karl Werdan
Journal:  Crit Care Med       Date:  2005-09       Impact factor: 7.598

3.  Early changes in organ function predict eventual survival in severe sepsis.

Authors:  Mitchell M Levy; William L Macias; Jean-Louis Vincent; James A Russell; Eliezer Silva; Benjamin Trzaskoma; Mark D Williams
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

4.  Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial.

Authors:  P J Godin; L A Fleisher; A Eidsath; R W Vandivier; H L Preas; S M Banks; T G Buchman; A F Suffredini
Journal:  Crit Care Med       Date:  1996-07       Impact factor: 7.598

5.  Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis.

Authors:  Martina Brueckmann; Guenter Huhle; Siegfried Lang; Karl K Haase; Thomas Bertsch; Christel Weiss; Jens J Kaden; Christian Putensen; Martin Borggrefe; Ursula Hoffmann
Journal:  Circulation       Date:  2005-07-18       Impact factor: 29.690

6.  Association between mitochondrial dysfunction and severity and outcome of septic shock.

Authors:  David Brealey; Michael Brand; Iain Hargreaves; Simon Heales; John Land; Ryszard Smolenski; Nathan A Davies; Chris E Cooper; Mervyn Singer
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

7.  Paroxysmal atrial fibrillation in critically ill patients with sepsis.

Authors:  Salam Salman; Abubakr Bajwa; Ognjen Gajic; Bekele Afessa
Journal:  J Intensive Care Med       Date:  2008-04-28       Impact factor: 3.510

8.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Perry Elliott; Bert Andersson; Eloisa Arbustini; Zofia Bilinska; Franco Cecchi; Philippe Charron; Olivier Dubourg; Uwe Kühl; Bernhard Maisch; William J McKenna; Lorenzo Monserrat; Sabine Pankuweit; Claudio Rapezzi; Petar Seferovic; Luigi Tavazzi; Andre Keren
Journal:  Eur Heart J       Date:  2007-10-04       Impact factor: 29.983

Review 9.  Sepsis and the heart.

Authors:  M W Merx; C Weber
Journal:  Circulation       Date:  2007-08-14       Impact factor: 29.690

10.  Septic cardiomyopathy - A not yet discovered cardiomyopathy?

Authors:  Ursula Muller-Werdan; Michael Buerke; Henning Ebelt; Konstantin M Heinroth; Anja Herklotz; Harald Loppnow; Martin Ruß; Frithjof Schlegel; Axel Schlitt; Hendrik B Schmidt; Gerold Söffker; Karl Werdan
Journal:  Exp Clin Cardiol       Date:  2006
View more
  3 in total

1.  Acute myocardial infarction and cardiogenic shock: prognostic impact of cytokines: INF-γ, TNF-α, MIP-1β, G-CSF, and MCP-1β.

Authors:  R Prondzinsky; S Unverzagt; H Lemm; N Wegener; K Heinroth; U Buerke; M Fiedler; J Thiery; J Haerting; K Werdan; M Buerke
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-07-20       Impact factor: 0.840

Review 2.  [Septic shock and septic cardiomyopathy].

Authors:  H Ebelt; K Werdan
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02-02       Impact factor: 0.840

3.  Fisetin inhibits lipopolysaccharide-induced inflammatory response by activating β-catenin, leading to a decrease in endotoxic shock.

Authors:  Ilandarage Menu Neelaka Molagoda; Jayasingha Arachchige Chathuranga Chanaka Jayasingha; Yung Hyun Choi; Rajapaksha Gedara Prasad Tharanga Jayasooriya; Chang-Hee Kang; Gi-Young Kim
Journal:  Sci Rep       Date:  2021-04-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.